These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24680084)

  • 1. Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)?
    Cotter R; Blacksburg S; Carpenter T; Kann B; Bakst R; Misiukiewicz K; Posner M; Som P; Gupta V
    Oral Oncol; 2014 Jun; 50(6):e27-8. PubMed ID: 24680084
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy.
    Lim Y; Keam B; Koh Y; Kim TM; Lee SH; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS; Kim KH
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jul; 116(1):55-60. PubMed ID: 23570665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324.
    Sher DJ; Posner MR; Tishler RB; Sarlis NJ; Haddad RI; Holupka EJ; Devlin PM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e813-8. PubMed ID: 21300455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Krstevska V
    J BUON; 2009; 14(3):361-73. PubMed ID: 19810125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.
    Lee KC; Lee SH; Lee Y; Park SH; Park J; Cho EK; Shin DB; Lee JH; Kim DY; Kim ST
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):187-91. PubMed ID: 17996392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction docetaxel, Cisplatin, and 5-Fluorouracil precludes definitive chemoradiotherapy in a substantial proportion of patients with head and neck cancer in a low socioeconomic status population.
    Caudell JJ; Hamilton RD; Otto KJ; Jennelle RL; Pitman KT; Vijayakumar S
    Am J Clin Oncol; 2014 Aug; 37(4):332-6. PubMed ID: 23275276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
    Tishler RB; Posner MR; Norris CM; Mahadevan A; Sullivan C; Goguen L; Wirth LJ; Costello R; Case M; Stowell S; Sammartino D; Busse PM; Haddad RI
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1036-44. PubMed ID: 16682134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy with carboplatin in continuous infusion in the locoregional control of advanced head and neck cancer.
    Marmiroli L; Nardone L; Salvi G; Ziccarelli P; Fiorentino G; Ausili-Cèfaro G
    Rays; 1998; 23(3):549-54. PubMed ID: 9932473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
    Vokes EE; Haraf DJ; Kies MS
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing.
    Dandekar V; Morgan T; Turian J; Fidler MJ; Showel J; Nielsen T; Coleman J; Diaz A; Sher DJ
    Oral Oncol; 2014 May; 50(5):520-6. PubMed ID: 24613544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined-modality therapy for head and neck cancer.
    Fu KK
    Oncology (Williston Park); 1997 Dec; 11(12):1781-90, 1796; discussion 1796, 179. PubMed ID: 9436185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Ready NE; Rathore R; Johnson TT; Nadeem A; Chougule P; Ruhl C; Radie-Keane K; Theall K; Wanebo HJ; Marcello J; Kennedy T
    Am J Clin Oncol; 2012 Feb; 35(1):6-12. PubMed ID: 21293244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease?
    Da Mosto MC; Lupato V; Romeo S; Spinato G; Addonisio G; Baggio V; Gava A; Boscolo-Rizzo P
    Ann Surg Oncol; 2013 Jan; 20(1):250-6. PubMed ID: 22836557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy: emerging treatment improvement strategies.
    Milas L; Mason KA; Liao Z; Ang KK
    Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?
    Paccagnella A; Mastromauro C; D'Amanzo P; Ghi MG
    Oncologist; 2010; 15 Suppl 3():8-12. PubMed ID: 21036883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined-modality therapy for locoregionally advanced head and neck cancer.
    Cmelak AJ; Murphy BA; Day T
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):83-91. PubMed ID: 10550831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.